-
Cambricon's first AI training chip completes mass production
Feb 7, 2021
Cambricon in the Zhongguancun Demonstration Zone announced on Jan 22 that the Siyuan 290 smart chip and accelerator card and the Xuansi 1000 smart accelerator have officially debuted after mass production.
-
4Paradigm raises $700 million in latest round of funding
Feb 3, 2021
4Paradigm announced the completion of its $700 million Series D funding round on Jan 22.
-
Open Source Ecology thrives in ZGC Software Park
Jan 28, 2021
The China Association for Science and Technology held the annual work conference of 2020 "Innovation China" on Jan 18, 2021.
-
TargetingOne completes largest domestic digital PCR financing
Jan 26, 2021
TargetingOne Technology Co Ltd in the Zhongguancun Demonstration Zone recently announced the completion of its Series B financing of 150 million yuan ($ 23.16 million).
-
-
JOINN Biologics licensed by FDA
Jan 22, 2021
JOINN Biologics Technology Co in the Zhongguancun Demonstration Zone recently passed review by the US Food and Drug Administration and was licensed for production, another milestone for the company after passing the EU Qualified Person (QP) audit.
-
EdiGene approved for clinical trial of China's first gene-editing therapy
Jan 22, 2021
The State Food and Drug Administration recently approved the clinical trial application of Zhongguancun Biopharmaceutical Enterprise EdiGene's gene-editing therapy product ET-01 for transfusion-dependent β-thalassemia.
-
ZGC Shunyi Park forms complete industry chain for 3rd-gen semiconductors
Jan 21, 2021
The third-generation semiconductor industry is one of the advanced sectors in Beijing.